SEC Info - Novartis Bioventures Ltd, et al. - ‘SC 13D’ on 10/1/14 re: Tokai Pharmaceuticals Inc

SEC Info℠

Home

Help

Please Sign In

Novartis Bioventures Ltd, et al. – ‘SC 13D’ on 10/1/14 re: Tokai Pharmaceuticals Inc – EX-99.2

On: Wednesday, 10/1/14, at 4:15pm ET · Accession #: 1193125-14-360795 · File #: 5-88334

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

10/01/14  Novartis Bioventures Ltd          SC 13D                 4:275K Tokai Pharmaceuticals Inc         RR Donnelley/FA
          Novartis AG

General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D      General Statement of Beneficial Ownership           HTML     66K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     10K 
 3: EX-99.2     Miscellaneous Exhibit                               HTML      4K 
 4: EX-99.3     Miscellaneous Exhibit                               HTML      7K

EX-99.2 — Miscellaneous Exhibit

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EX-99.2

Exhibit 99.2

Evidence of Signature Authority

Excerpt from Commercial Register

LOGO

↑Top

Filing Submission 0001193125-14-360795 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Novartis Bioventures Ltd, et al. – ‘SC 13D’ on 10/1/14 re: Tokai Pharmaceuticals Inc – EX-99.2

On: Wednesday, 10/1/14, at 4:15pm ET · Accession #: 1193125-14-360795 · File #: 5-88334

Previous ‘SC 13D’: ‘SC 13D/A’ on 2/4/11 · Next: ‘SC 13D’ on 3/27/17 · Latest: ‘SC 13D/A’ on 5/15/20

General Statement of Beneficial Ownership — Schedule 13DFiling Table of Contents

EX-99.2 — Miscellaneous Exhibit

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents